Eric Samples Joins PetVivo Holdings, Inc. as a Field Veterinary Business Development Manager
PetVivo Holdings, Inc. (OTCQB: PETV & PETVW), a biomedical device company focused on innovative medical devices for companion animals, has appointed Eric Samples as its new Field Veterinary Business Development Manager for Ohio, Pennsylvania, and the Baltimore/DC area. Eric brings over 25 years of human and animal health sales experience to PetVivo, including roles at Covetrus, Sanofi Pharmaceuticals, and Fort Dodge Animal Health.
CEO John Lai expressed excitement about Eric's addition to the team, highlighting his valuable experience in advancing awareness of PetVivo's product Spryng™ with OsteoCushion™ technology. Eric, who holds a degree in Dairy and Animal Science from Penn State University, stated his enthusiasm for joining PetVivo and believes Spryng has the potential to improve medical outcomes for animals suffering from lameness and joint-related afflictions.
PetVivo Holdings, Inc. (OTCQB: PETV & PETVW), un'azienda di dispositivi biomedici focalizzata su dispositivi medici innovativi per animali da compagnia, ha nominato Eric Samples come nuovo Manager Sviluppo Commerciale Veterinario sul Campo per Ohio, Pennsylvania e l'area di Baltimora/DC. Eric porta con sé oltre 25 anni di esperienza nella vendita di prodotti per la salute umana e animale a PetVivo, comprese esperienze lavorative presso Covetrus, Sanofi Pharmaceuticals e Fort Dodge Animal Health.
Il CEO John Lai ha espresso entusiasmo per l'aggiunta di Eric al team, evidenziando la sua preziosa esperienza nel promuovere la consapevolezza riguardo al prodotto di PetVivo, Spryng™ con tecnologia OsteoCushion™. Eric, che possiede una laurea in Scienze Zootecniche e Animali presso la Penn State University, ha dichiarato il suo entusiasmo per entrare a far parte di PetVivo e crede che Spryng possa migliorare gli esiti medici per gli animali che soffrono di zoppia e affezioni articolari.
PetVivo Holdings, Inc. (OTCQB: PETV & PETVW), una empresa de dispositivos biomédicos enfocada en dispositivos médicos innovadores para animales de compañía, ha nombrado a Eric Samples como su nuevo Gerente de Desarrollo Comercial Veterinario en el Campo para Ohio, Pennsylvania y el área de Baltimore/DC. Eric aporta más de 25 años de experiencia en ventas de salud humana y animal a PetVivo, incluidas funciones en Covetrus, Sanofi Pharmaceuticals y Fort Dodge Animal Health.
El CEO John Lai expresó su entusiasmo por la incorporación de Eric al equipo, destacando su valiosa experiencia en promover la conciencia sobre el producto de PetVivo, Spryng™ con tecnología OsteoCushion™. Eric, quien tiene un título en Ciencias Lácteas y Animales de la Universidad Estatal de Pensilvania, afirmó su entusiasmo por unirse a PetVivo y cree que Spryng tiene el potencial de mejorar los resultados médicos para los animales que sufren de cojera y afecciones articulares.
PetVivo Holdings, Inc. (OTCQB: PETV & PETVW)는 반려동물을 위한 혁신적인 의료 기기에 중점을 둔 생의학 기기 회사로, Eric Samples를 오하이오, 펜실베이니아 및 볼티모어/DC 지역의 새로운 현장 수의학 사업 개발 관리자로 임명했습니다. Eric은 Covetrus, Sanofi Pharmaceuticals 및 Fort Dodge Animal Health에서의 역할을 포함하여 인간 및 동물 건강 판매 경험이 25년 이상 됩니다.
CEO John Lai는 팀에 Eric이 합류하게 된 것에 대한 기대감을 표명하며, PetVivo의 제품 Spryng™과 OsteoCushion™ 기술에 대한 인식을 제고하는 데 있어 그의 소중한 경험을 강조했습니다. Penn State University에서 유제품 및 동물 과학 학위를 가진 Eric은 PetVivo에 합류하게 된 것에 대한 열정을 표명하며, Spryng가 절름거림 및 관절 관련 질환으로 고통받는 동물의 치료 결과를 개선할 수 있는 잠재력이 있다고 믿습니다.
PetVivo Holdings, Inc. (OTCQB: PETV & PETVW), une entreprise de dispositifs biomédicaux axée sur les dispositifs médicaux innovants pour les animaux de compagnie, a nommé Eric Samples comme nouveau Responsable du Développement Commercial Vétérinaire Terrain pour l'Ohio, la Pennsylvanie et la région de Baltimore/DC. Eric apporte plus de 25 ans d'expérience en ventes dans le domaine de la santé humaine et animale à PetVivo, y compris des postes chez Covetrus, Sanofi Pharmaceuticals et Fort Dodge Animal Health.
Le PDG John Lai a exprimé son enthousiasme quant à l'ajout d'Eric à l'équipe, soulignant son expérience précieuse dans la sensibilisation au produit de PetVivo Spryng™ avec la technologie OsteoCushion™. Eric, qui possède un diplôme en Sciences Laitières et Animales de l'Université d'État de Pennsylvanie, a déclaré être enthousiaste à l'idée de rejoindre PetVivo et croit que Spryng a le potentiel de améliorer les résultats médicaux pour les animaux souffrant de boiterie et de problèmes articulaires.
PetVivo Holdings, Inc. (OTCQB: PETV & PETVW), ein biomedizinisches Geräteunternehmen, das sich auf innovative medizinische Geräte für Haustiere konzentriert, hat Eric Samples als neuen Field Veterinary Business Development Manager für Ohio, Pennsylvania und das Gebiet Baltimore/DC ernannt. Eric bringt über 25 Jahre Erfahrung im Vertrieb von Gesundheitsprodukten für Mensch und Tier zu PetVivo mit, darunter Positionen bei Covetrus, Sanofi Pharmaceuticals und Fort Dodge Animal Health.
CEO John Lai äußerte sich begeistert über Erics Neuzugang im Team und hob seine wertvolle Erfahrung hervor, die Bekanntheit des PetVivo-Produkts Spryng™ mit OsteoCushion™ Technologie voranzubringen. Eric, der einen Abschluss in Milchwirtschaft und Tierwissenschaften von der Penn State University hält, erklärte seine Begeisterung, Teil von PetVivo zu werden, und glaubt, dass Spryng das Potenzial hat, medizinische Ergebnisse für Tiere mit Lahmheit und gelenkbezogenen Erkrankungen zu verbessern.
- Appointment of experienced Field Veterinary Business Development Manager
- Expansion of sales coverage to Ohio, Pennsylvania, and Baltimore/DC area
- New hire brings 25+ years of human and animal health sales experience
- None.
MINNEAPOLIS, MN, US, Aug. 12, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV & PETVW) (the "Company") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals and animal athletes is pleased to announce that Eric Samples has accepted a position with the Company as its new Field Veterinary Business Development Manager to cover Ohio, Pennsylvania, and the Baltimore/DC area of the United States.
"We are incredibly excited to add Eric to our sales and distribution team,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “The experience Eric brings to PetVivo is extraordinarily valuable to our efforts in advancing awareness of our innovative product Spryng™ with OsteoCushion™ technology to veterinarians throughout Ohio, Pennsylvania, and the Baltimore/DC area”
Eric Samples brings to PetVivo more than 25 years of human and animal health sales and management experience. His love of animals took him to Penn State University where he earned a degree in Dairy and Animal Science. Most recently Eric achieved & exceeded sales goals while calling on companion, equine & livestock veterinarians for Covetrus. Additionally, Eric’s career has provided valuable sales experience in roles such as senior sales specialist for Sanofi Pharmaceuticals as well as selling healthcare products on behalf of entities such as Eisai Pharmaceuticals, Pfizer Healthcare, Johnson and Johnson, Bristol-Meyers Squib, Innovex and Fort Dodge Animal Health.
“I am incredibly excited to have the opportunity to join the PetVivo sales and distribution team. Growing up with a veterinarian as a father, it has always been my ambition to engage in a career that enriches the lives of companion animals,” said Mr. Samples. “I truly believe Spryng with OsteoCushion Technology has the ability to improve the medical outcomes of animals suffering from lameness and other joint related afflictions, such as osteoarthritis, thereby enhancing their lives as well as the lives of their owners.”
About PetVivo Holdings
PetVivo Holdings, Inc. (OTCQB: PETV, PETVW) is a biomedical device company focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The company is pursuing a strategy of developing and commercializing human therapies for the treatment of companion animals in capital and time efficient ways. A key component of this strategy is an accelerated timeline to revenues for veterinary medical devices that can enter the market much earlier than more stringently regulated human pharmaceuticals and biologics.
PetVivo has developed a robust pipeline of products for the medical treatment of animals and people, with a portfolio of 21 patents that protect the company's biomaterials, products, production processes and methods of use. The company’s commercially launched flagship product, Spryng™ with OsteoCushion™ Technology, is a veterinarian-administered, intra-articular injectable designed for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses.
For more information about PetVivo and its revolutionary Spryng with OsteoCushion Technology, email info1@petvivo.com or visit petvivo.com or sprynghealth.com.
Disclosure Information
PetVivo uses and intends to continue to use its Investor Relations website as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor the company’s Investor Relations website, in addition to following the company’s press releases, SEC filings, public conference calls, presentations and webcasts.
Forward-Looking commercial Statements
The foregoing information regarding PetVivo Holdings, Inc. (the “Company”) may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company’s proposed development and commercial timelines, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company’s business are described in detail in the Company’s Annual Report on Form 10-K for the year ended March 31, 2024 and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Company Contact
John Lai, CEO
PetVivo Holdings, Inc.
Email Contact
Tel (952) 405-6216
Investor Contact
Ronald Both or Grant Stude
CMA Investor Relations
Tel (949) 432-7566
Email contact
Attachment
FAQ
Who is Eric Samples and what is his new role at PetVivo Holdings (PETV)?
What is PetVivo's (PETV) main product for animal health?
What regions will Eric Samples cover in his new role at PetVivo (PETV)?
What is Eric Samples' educational background relevant to his position at PetVivo (PETV)?
